Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition

In this cohort study, pricing data from January 2007 to June 2018 from SSR Health were used to determine how list prices, net prices, and discounts for the originator biologics changed with biosimilar competition.

Detalles Bibliográficos
Autores principales: San-Juan-Rodriguez, Alvaro, Gellad, Walid F., Good, Chester B., Hernandez, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938676/
https://www.ncbi.nlm.nih.gov/pubmed/31834391
http://dx.doi.org/10.1001/jamanetworkopen.2019.17379
Descripción
Sumario:In this cohort study, pricing data from January 2007 to June 2018 from SSR Health were used to determine how list prices, net prices, and discounts for the originator biologics changed with biosimilar competition.

Ejemplares similares